检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李飞[1] 吴红[1] 张慧[1] 范黎[1] 张海涛[1] 任波[2]
机构地区:[1]第四军医大学药学系化学教研室,陕西西安710032 [2]解放军第302医院,北京100039
出 处:《解放军药学学报》2008年第5期377-381,共5页Pharmaceutical Journal of Chinese People's Liberation Army
基 金:国家自然科学基金资助项目;No.30300456;30770573;全军医药卫生科研基金课题;No.06Q064
摘 要:目的制备具有pH/温度双重敏感的聚(马来酰化葡聚糖/N-异丙基丙烯酰胺)[P(Dex-MA/NIPA)]纳米凝胶,研究释药特性。方法乳液聚合法制备不同配比的聚(马来酰化葡聚糖/N-异丙基丙烯酰胺)纳米凝胶,测定临界相变温度(LCST)以及不同pH下的粒径;以羟基喜树碱(HPCT)为药物模型,动态透析法研究其不同pH和温度下的智能释药特性。结果P(Dex-MA/NIPA)纳米凝胶的LCST与Dex/MA和NIPA的比例有关,并且可调节至35-45℃;pH2.0、7.5的缓冲液里,粒径分别为62、273nm,包裹率、载药率分别为62.94%、0.82%。37℃时在pH为2.0、5.0、7.5的缓冲液中12h后的药物释放累积率为11%、19.65%、33%;pH7.5时在37、40~C的介质中4h后药物释放累积率分别为15%、25%。结论P(Dex-MA/NIPA)纳米凝胶具有pH/温度双重敏感性,有望成为智能型控释和靶向性抗肿瘤药物载体。Aim To prepare pH and temperature sensitive p(Dex-MA/NIPA) nanoparticles, and study the prop- erties of the drug release. Methods P( maleilated dextran/N-isopropylacrylamide) (p(Dex-MA/NIPA))nanopartieles were first synthesized by emulsion polymerization. At different pH, temperatures, size distribution and drug release of p(Dex-MA/NIPA) nanoparticles were determined. Results The size of nanoparticles was 62nm and 273nm in different pH buffer solutions, p (Dex-MA/NIPA) nanoparticles with lower critical solution temperatures (LCST) ranging from 35℃ to 45℃ were correlated to the molar fraction of maleilated dextran copolymerized with NIPA. Drug loading and encapsulation efficiency were 62.94% ,0.82% respectively. In vitro drug release there were sig- nificant differences in different pH and temperatures. Conclusion p (Dex-MA/NIPA) nanoparticles respond to pH and temperature stimulis, which are promising candidates for novel drug carriers with advantages of controlled re- lease and targeting effect.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.44